Loading company…
Myelo Therapeutics GmbH is a Berlin biopharmaceutical company developing countermeasures for radiation exposure and therapies for chemotherapy side effects.
Myelo Therapeutics GmbH is a Berlin, Germany biopharmaceutical company that develops medical countermeasures against radiation exposure and supportive therapies for cancer patients receiving chemotherapy. Its customers are mainly hospitals, cancer treatment centers and government agencies. CEO Dirk Pleimes leads the company, which has noted 7 deals. In June 2020 it raised venture funding led by returning investor Eckert & Ziegler, with terms not disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in